Wednesday, September 29, 2010

'happy coffins'


SINGAPORE (AFP) – A Singapore charity on Tuesday announced the winners of an international art competition to design "happy coffins" to encourage the elderly and dying to celebrate life.

Six winning designs out of 733 entries from 37 countries were made into personalised coffins in cooperation with a local funeral home.

The first prize of 3,000 US dollars went to a 27-year-old Belgian woman, Ines van Gucht, whose design showed a furry black creature whom she described as a friend that would take care of her after her death.

A message on the figure read: "Hello coffin. You seem to be nice. One day we will meet again. To the rest of you I say goodbye. I hope it was a blast."

Other entries included a coffin designed to resemble chocolate bars and another depicting the dishes of a "last supper" served on the top.

Under the slogan "My Life, My Coffin" the foundation said it wanted to encourage people to think "out of the box" about taboos surrounding death.

Three elderly Singaporean women living in a Roman Catholic shelter, St. Joseph's Home and Hospice, co-designed their own coffins with young local artists as part of the project.

"I'm very pleased with it," Elsie Chua, 76, said with a serene smile as she sat in a wheelchair beside a white coffin with blue drawings of a young woman at a sewing machine surrounded by roses, birds, butterflies and a reindeer.

"I was a seamstress before and I sewed dresses for my mother, and that's why I chose it and the designer designed it for me," she told journalists.

The project was spearheaded by the local Lien Foundation, which favours non-traditional forms of philanthropy.

"This is to me part art, part social initiative to transform coffins -- to me they are a supreme symbol of death -- into a creative canvas for the reflection and celebration of life," said Lee Poh Wah, the foundation's chief executive officer.

Stem cell treatment for heart attack

TORONTO (Reuters) – Angiotech Pharmaceuticals and partner Athersys Inc said on Thursday their early-stage clinical trial of a stem cell therapy for heart attack patients showed improved heart function and was well-tolerated at all dosages.

Shares of Vancouver-based Angiotech climbed 10 percent late on Thursday afternoon to 57 Canadian cents on the Toronto Stock Exchange. U.S.-based Athersys was up 0.5 percent at $3.18 on the Nasdaq.

Patients undergoing the MultiStem treatment displayed mild to moderate side effects, Angiotech said.

Data from the early-stage trial suggested that treated patients showed improvements in heart function compared with patients receiving standard care, it said.

The update of the phase I clinical trial was based on four months of post-treatment data.

The companies said they are planning a subsequent clinical study, with trials expected in begin in 2011.

This week, Athersys said MultiStem also received orphan drug status in the United States for the prevention of a condition that causes immunologic attacks in bone-marrow transplant patients.

This is a designation granted by the U.S. Food and Drug Administration to drugs that treat a condition affecting less than 200,000 Americans. It grants the drugmaker marketing exclusivity for seven years in the United States after approval.

($1=$1.03 Canadian)

(Reporting by Solarina Ho; editing by Peter Galloway)

'Goldilocks' <> NEW PLANET JUST LIKE EARTH


'Goldilocks' planet"

A team of planet-hunting scientists say they've discovered a planet 20 light years from earth that could be the most earth-like body ever found


Saturday, September 11, 2010

discovery of antibiotic resistance

The next antibiotics you take just may come from the lowly cockroach. Scientists in the UK have discovered nine different molecules inside the brains and nervous systems of the insects which can kill over 90% of methicillin-resistent staphylococcus aureus (MRSA) and. E. coli

, all without harming human cells. Simon Lee, a researcher in the study says, “Insects often live in unsanitary and unhygienic environments where they encounter many different types of bacteria. It is therefore logical that they have developed ways of protecting themselves against micro-organisms.” This is certainly a welcomed discovery as antibiotic resistance
is fast becoming a tremendous problem around the world.
[via Daily Mail]